Event listings current as of Thursday, Oct. 25, 2024. Visit the Mobile Meeting Guide App for more details. 11 2024 INDUSTRY EVENTS Antiarrhythmic Drugs in Atrial Fibrillation: Putting the Guideline Into Practice 11:15 a.m.-12 p.m. Learning Studio I SUPPORTER: Sanofi Evaluating Long-Term Outcomes and Real-World Impact of Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II-III Obstructive HCM 11:15 a.m.-12 p.m. Heart Theater I SUPPORTER: Bristol-Myers Squibb Managing LDL-C With LEQVIO® (inclisiran) After a Recent Coronary Event: Putting Evidence Into Practice 11:15 a.m.-12 p.m. Learning Studio II SUPPORTER: Novartis Pharmaceutical Corporation A New Era in the Treatment of Hypertension 11:15 a.m.-12 p.m. Heart Theater II SUPPORTER: Idorsia Pharmaceuticals Ltd A Development for Adults With Pulmonary Arterial Hypertension 12:30-1:15 p.m. Learning Studio I SUPPORTER: Merck & Co. Address the Gap: Elevate Care for CVD With Urgent LDL-C Management 12:30-1:15 p.m. Learning Studio II SUPPORTER: Amgen Inc GDMT and Hyperkalemia: A Crossroad for Cardiology, Finding an Optimal Path 12:30-1:15 p.m. Heart Theater I SUPPORTER: AstraZeneca The Future of AI in Cardiology: Trends, Expert Insights and Panel Discussion 12:30-1:15 p.m. Heart Theater II SUPPORTER: Anumana, Inc. Sunday, Nov. 17
RkJQdWJsaXNoZXIy MjI2NjI=